CliffBio
small molecule

SYMBICORT AEROSPHERE

BUDESONIDE; FORMOTEROL FUMARATE

Loss of exclusivityMay 2030latest FDA-listed patent expiry
CompanyASTRAZENECA PHARMACEUTICALS LP

Drug detail

Brand nameSYMBICORT AEROSPHERE
Active ingredientBUDESONIDE; FORMOTEROL FUMARATE
Strength0.16MG/INH;0.0048MG/INH
Dosage formAEROSOL, METERED
RouteINHALATION
ModalitySmall molecule
FDA approvalApril 2023
Marketing statusRX

Listed patents

PatentExpiresType
10716753May 2030product
9415009May 2030use U-4513

Regulatory exclusivity

CodeExpires
I-988April 2029

More from ASTRAZENECA PHARMACEUTICALS LP

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

SYMBICORT AEROSPHERE patent cliff — loss of exclusivity May 2030 | CliffBio